| Entry |
|
| Name |
Pancreatic cancer - Ornithorhynchus anatinus (platypus)
|
| Description |
Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term 'pancreatic cancer' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.
|
| Class |
Human Diseases; Cancers
 |
| Pathway map |

  |
| Organism |
Ornithorhynchus anatinus (platypus) [GN: oaa]
|
| Gene |
| GTPase KRas-like; K07827 GTPase KRas [KO: K07827] | | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO: K00922] [EC: 2.7.1.153] | | | | | | phosphoinositide 3-kinase regulatory subunit 5-like; K02649 phosphoinositide-3-kinase, regulatory subunit [KO: K02649] | | PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO: K02649] | | phosphatidylinositol 3-kinase regulatory subunit alpha-like; K02649 phosphoinositide-3-kinase, regulatory subunit [KO: K02649] | | phosphatidylinositol 3-kinase regulatory subunit gamma-like; K02649 phosphoinositide-3-kinase, regulatory subunit [KO: K02649] | | ARHGEF6; Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 [KO: K05729] | | ras-related C3 botulinum toxin substrate 1-like; K04392 Ras-related C3 botulinum toxin substrate 1 [KO: K04392] | | ras-related C3 botulinum toxin substrate 2-like; K07860 Ras-related C3 botulinum toxin substrate 2 [KO: K07860] | | nuclear factor NF-kappa-B p105 subunit-like; K02580 nuclear factor NF-kappa-B p105 subunit [KO: K02580] | | nuclear factor NF-kappa-B p105 subunit-like; K02580 nuclear factor NF-kappa-B p105 subunit [KO: K02580] | | transcription factor p65-like; K04735 transcription factor p65 [KO: K04735] | | RAC-gamma serine/threonine-protein kinase-like; K04456 RAC serine/threonine-protein kinase [EC: 2.7.11.1] [KO: K04456] [EC: 2.7.11.1] | | RAC-alpha serine/threonine-protein kinase-like; K04456 RAC serine/threonine-protein kinase [EC: 2.7.11.1] [KO: K04456] [EC: 2.7.11.1] | | CHUK; conserved helix-loop-helix ubiquitous kinase [KO: K04467] [EC: 2.7.11.10] | | IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO: K07209] [EC: 2.7.11.10] | | NF-kappa-B essential modulator-like; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma [KO: K07210] | | | | serine/threonine-protein kinase A-Raf-like; K08845 A-Raf proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] [KO: K08845] [EC: 2.7.11.1] | | serine/threonine-protein kinase B-raf-like; K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] [KO: K04365] [EC: 2.7.11.1] | | RAF proto-oncogene serine/threonine-protein kinase-like; K04366 RAF proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] [KO: K04366] [EC: 2.7.11.1] | | dual specificity mitogen-activated protein kinase kinase 1-like; K04368 mitogen-activated protein kinase kinase 1 [EC: 2.7.12.2] [KO: K04368] [EC: 2.7.12.2] | | mitogen-activated protein kinase 1-like; K04371 extracellular signal-regulated kinase 1/2 [EC: 2.7.11.24] [KO: K04371] [EC: 2.7.11.24] | | | | | | | | ral guanine nucleotide dissociation stimulator-like; K08732 ral guanine nucleotide dissociation stimulator [KO: K08732] | | ras-related protein Ral-A-like; K07834 Ras-related protein Ral-A [KO: K07834] | | ras-related protein ralB-B-like; K07835 Ras-related protein Ral-B [KO: K07835] | | RALBP1; ralA binding protein 1 [KO: K08773] | | cell division control protein 42 homolog; K04393 cell division control protein 42 [KO: K04393] | | protransforming growth factor alpha-like; K08774 transforming growth factor, alpha [KO: K08774] | | | | signal transducer and activator of transcription 1-like; K11220 signal transducer and activator of transcription 1 [KO: K11220] | | vascular endothelial growth factor A-like; K05448 vascular endothelial growth factor A [KO: K05448] | | cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A [KO: K06621] | | | | G1/S-specific cyclin-D1-like; K04503 cyclin D1 [KO: K04503] | | RB1; retinoblastoma 1 [KO: K06618] | | transcription factor E2F3-like; K06620 E2F transcription factor 1/3 [KO: K06620] | | transcription factor E2F2-like; K09389 E2F transcription factor 2 [KO: K09389] | | transforming growth factor beta-2-like; K13376 transforming growth factor beta-2 [KO: K13376] | | transforming growth factor beta-3-like; K13377 transforming growth factor beta-3 [KO: K13377] | | | | TGFBR2; transforming growth factor, beta receptor II (70/80kDa) [KO: K04388] [EC: 2.7.11.30] | | SMAD2; SMAD family member 2 [KO: K04500] | | mothers against decapentaplegic homolog 4-like; K04501 mothers against decapentaplegic homolog 4 [KO: K04501] | | BRCA2; breast cancer 2, early onset [KO: K08775] | | DNA repair protein RAD51 homolog 1-like; K04482 DNA repair protein RAD51 [KO: K04482] | | DNA repair protein RAD51 homolog 1-like; K04482 DNA repair protein RAD51 [KO: K04482] |
|
| Compound |
| Phosphatidate | | Phosphatidylinositol-3,4,5-trisphosphate |
|
| Reference |
|
| Authors |
Von Hoff DD, Evans DB, Hruban RH (ed). |
| Title |
Pancreatic Cancer |
| Journal |
Jones and bartlett publishers (2005) |
| Reference |
(Japanese) |
| Authors |
Niitsu Y, Yokota J (ed). |
| Title |
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese) |
| Journal |
Nankodo (1999) |
| Reference |
|
| Authors |
Bardeesy N, DePinho RA. |
| Title |
Pancreatic cancer biology and genetics. |
| Journal |
Nat Rev Cancer 2:897-909 (2002) |
| Reference |
|
| Authors |
Bardeesy N, Sharpless NE, DePinho RA, Merlino G. |
| Title |
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. |
| Journal |
Semin Cancer Biol 11:201-18 (2001) |
| Reference |
|
| Authors |
Cowgill SM, Muscarella P. |
| Title |
The genetics of pancreatic cancer. |
| Journal |
Am J Surg 186:279-86 (2003) |
| Reference |
|
| Authors |
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. |
| Title |
Genetics and biology of pancreatic ductal adenocarcinoma. |
| Journal |
Genes Dev 20:1218-49 (2006) |
| Reference |
|
| Authors |
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. |
| Title |
Understanding Ras: 'it ain't over 'til it's over'. |
| Journal |
Trends Cell Biol 10:147-54 (2000) |
| Reference |
|
| Authors |
Holbro T, Civenni G, Hynes NE. |
| Title |
The ErbB receptors and their role in cancer progression. |
| Journal |
Exp Cell Res 284:99-110 (2003) |
| Reference |
|
| Authors |
Marmor MD, Skaria KB, Yarden Y. |
| Title |
Signal transduction and oncogenesis by ErbB/HER receptors. |
| Journal |
Int J Radiat Oncol Biol Phys 58:903-13 (2004) |
| Reference |
|
| Authors |
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW. |
| Title |
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. |
| Journal |
Oncogene 22:7781-95 (2003) |
| Reference |
|
| Authors |
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. |
| Title |
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. |
| Journal |
Oncogene 22:319-29 (2003) |
| Reference |
|
| Authors |
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M. |
| Title |
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. |
| Journal |
Cancer Lett 201:107-16 (2003) |
| Reference |
|
| Authors |
Schmid RM. |
| Title |
Genetic basis of pancreatic cancer. |
| Journal |
Best Pract Res Clin Gastroenterol 16:421-33 (2002) |
| Reference |
|
| Authors |
Elliott RL, Blobe GC. |
| Title |
Role of transforming growth factor Beta in human cancer. |
| Journal |
J Clin Oncol 23:2078-93 (2005) |
| Reference |
|
| Authors |
Rudkin TM, Foulkes WD. |
| Title |
BRCA2: breaks, mistakes and failed separations. |
| Journal |
Trends Mol Med 11:145-8 (2005) |
| Reference |
|
| Authors |
Venkitaraman AR. |
| Title |
Functions of BRCA1 and BRCA2 in the biological response to DNA damage. |
| Journal |
J Cell Sci 114:3591-8 (2001) |
| KO pathway |
|